Role of HDAC3-miRNA-CAGE Network in Anti-Cancer Drug-Resistance

Citations

WEB OF SCIENCE

27
Citations

SCOPUS

26

초록

Histone modification is associated with resistance to anti-cancer drugs. Epigenetic modifications of histones can regulate resistance to anti-cancer drugs. It has been reported that histone deacetylase 3 (HDAC3) regulates responses to anti-cancer drugs, angiogenic potential, and tumorigenic potential of cancer cells in association with cancer-associated genes (CAGE), and in particular, a cancer/testis antigen gene. In this paper, we report the roles of microRNAs that regulate the expression of HDAC3 and CAGE involved in resistance to anti-cancer drugs and associated mechanisms. In this review, roles of HDAC3-miRNAs-CAGE molecular networks in resistance to anti-cancer drugs, and the relevance of HDAC3 as a target for developing anti-cancer drugs are discussed.

키워드

anti-cancer drug-resistance; histone deacetylase-3; cancer; testis antigen CAGE; epidermal growth factor receptor; micro RNAs; molecular network; HISTONE DEACETYLASE INHIBITORS; CANCER/TESTIS ANTIGEN CAGE; CANCER STEM-CELLS; B-DEPENDENT TRANSCRIPTION; FEEDBACK LOOP; BREAST-CANCER; GASTRIC-CANCER; EXPRESSION; HDAC3; DIFFERENTIATION
제목
Role of HDAC3-miRNA-CAGE Network in Anti-Cancer Drug-Resistance
저자
Kwon, Yoojung; Kim, Youngmi; Jung, Hyun Suk; Jeoung, Dooil
DOI
10.3390/ijms20010051
발행일
2019-01-01
유형
Review
저널명
International Journal of Molecular Sciences
권
20
호
1